Screening for affective dysregulation in school-aged children: relationship with comprehensive measures of affective dysregulation and related mental disorders.

Affective dysregulation (AD) is characterized by irritability, severe temper outbursts, anger, and unpredictable mood swings, and is typically classified as a transdiagnostic entity. A reliable and valid measure is needed to adequately identify children at risk of AD. This study sought to validate a parent-rated screening questionnaire, which is part of the comprehensive Diagnostic Tool for Affective Dysregulation in Children (DADYS-Screen), by analyzing relationships with comprehensive measures of AD and related mental disorders in a community sample of children with and without AD. The sample comprised 1114 children aged 8-12 years and their parents. We used clinical, parent, and child ratings for our analyses. Across all raters, the DADYS-Screen showed large correlations with comprehensive measures of AD. As expected, correlations were stronger for measures of externalizing symptoms than for measures of internalizing symptoms. Moreover, we found negative associations with emotion regulation strategies and health-related quality of life. In receiver operating characteristic (ROC) analyses, the DADYS-Screen adequately identified children with AD and provided an optimal cut-off. We conclude that the DADYS-Screen appears to be a reliable and valid measure to identify school-aged children at risk of AD.

Livestock as possible reservoir of Escherichia albertii in Switzerland.

INTRODUCTION: Escherichia albertii is an emerging zoonotic foodborne pathogen. Its prevalence, distribution, and reservoirs are not yet clearly defined. In this study, we evaluated the occurrence and genomic characteristics of E. albertii in livestock from Switzerland. A total of 515 caecal samples from sheep, cattle, calves, and fattening swine were collected between May 2022 and August 2022 at abattoir level. Using an E. albertii-specific PCR targeting the Eacdt-gene, 23,7 % (51/215) of swine from 24 different farms were positive. One (1 %) out of 100 calves showed a positive PCR result, while all samples from sheep and cattle were PCR negative. Eight E. albertii isolates could be recovered from swine samples and were analysed using whole-genome sequencing. All eight isolates belonged to ST2087 or a ST4619 group subclade, as did most genomes of the 11 available global swine isolates from public databases. These two clusters shared the presence of a virulence plasmid harboring the sitABCD and iuc genes. In summary, we demonstrate that fattening swine constitute an E. albertii reservoir in Switzerland and describe specific swine-associated lineages.

INTRODUCTION: Escherichia albertii est un pathogène alimentaire zoonotique émergent. Sa prévalence, sa distribution et ses réservoirs ne sont pas encore clairement définis. Dans cette étude, nous avons évalué l'occurrence et les caractéristiques génomiques d'E. albertii chez le bétail en Suisse. Au total, 515 échantillons cæcaux d'ovins, de bovins, de veaux et de porcs d'engraissement ont été prélevés entre mai 2022 et août 2022 au niveau de l'abattoir. En utilisant une PCR spécifique à E. albertii ciblant le gène Eacdt, 23,7 % (51/215) des porcs provenant de 24 exploitations différentes étaient positifs. Un (1 %) veau sur 100 a présenté un résultat positif à la PCR, tandis que tous les échantillons d'ovins et de bovins étaient négatifs à la PCR. Huit isolats d'E. albertii ont pu être récupérés à partir d'échantillons provenant de porcs et ont été analysés par séquençage du génome entier. Les huit isolats appartenaient au groupe ST2087 ou à un sous-clade du groupe ST4619, comme la plupart des génomes des 11 isolats porcins mondiaux disponibles dans les bases de données publiques. Ces deux groupes partageaient la présence d'un plasmide de virulence hébergeant les gènes sitABCD et iuc. En résumé, nous démontrons que les porcs d'engraissement constituent un réservoir d'E. albertii en Suisse et décrivons des lignées spécifiques associées aux porcs.

Impact of the COVID-19 pandemic on children with and without affective dysregulation and their families.

Analyzing COVID-19-related stress in children with affective dysregulation (AD) seems especially interesting, as these children typically show heightened reactivity to potential stressors and an increased use of maladaptive emotion regulation strategies. Children in out-of-home care often show similar characteristics to those with AD. Since COVID-19 has led to interruptions in psychotherapy for children with mental health problems and to potentially reduced resources to implement treatment strategies in daily life in families or in out-of-home care, these children might show a particularly strong increase in stress levels. In this study, 512 families of children without AD and 269 families of children with AD reported on COVID-19-related stress. The sample comprised screened community, clinical, and out-of-home care samples. Sociodemographic factors, characteristics of child and caregiver before the pandemic, and perceived change in external conditions due to the pandemic were examined as potential risk or protective factors. Interestingly, only small differences emerged between families of children with and without AD or between subsamples: families of children with AD and families in out-of-home care were affected slightly more, but in few domains. Improvements and deteriorations in treatment-related effects balanced each other out. Overall, the most stable and strongest risk factor for COVID-19-related stress was perceived negative change in external conditions-particularly family conditions and leisure options. Additionally, caregiver characteristics emerged as risk factors across most models. Actions to support families during the pandemic should, therefore, facilitate external conditions and focus on caregiver characteristic to reduce familial COVID-19-related stress. Trial registration: German Clinical Trials Register (DRKS), ADOPT Online: DRKS00014963 registered 27 June 2018, ADOPT Treatment: DRKS00013317 registered 27 September 2018, ADOPT Institution: DRKS00014581 registered 04 July 2018.

The massive expression of c-fos protein in spinal dorsal horn neurons is not followed by long-term changes in spinal nociception.

It has been suggested that the expression of c-fos and other immediate early genes in spinal dorsal horn neurons would trigger changes in the phenotype of nociceptive neurons which may lead to long-term changes in spinal nociception. To test this hypothesis, we have used a minimally invasive intrathecal stimulation and injection technique which can be applied to adult Sprague-Dawley rats under brief ether anesthesia to induce massive c-fos expression in spinal neurons without affecting peripheral nociceptors. Electrical intrathecal stimulation (0.5 ms pulses, 15 V, 3 Hz for 15 min) or intrathecal injection of N-methyl-D-aspartate (25 nmol) produced massive c-Fos immunoreactivity in neurons throughout the sacral spinal cord and the dorsal horn of the lumber spinal cord. Immunoreactivity declined to control values at mid-thoracic levels. To assess effects of these intrathecal stimuli on nociception, hot-plate and tail-flick latencies and mechanical thresholds of hindlimb withdrawal reflexes were measured once every day for 14 days before and up to 14 days after conditioning stimulation. Spontaneous locomotion of each animal was video-taped daily for 5 min and analysed off-line. On the day of the intrathecal stimulation the tests were performed 1 h before and also 6 h after conditioning stimulation. Thermal and mechanical nociceptive thresholds were temporarily enhanced 6 h after intrathecal stimulation but they were not different from controls one to 14 days later. Thus, the massive expression of c-fos in spinal neurons is not, as previously suggested, a sufficient condition for the induction of long-term changes in spinal nociception.

[Parvovirus B19-induced arthritis/arthropathy--an important differential diagnosis of chronic polyarthritis]. / Parvovirus-B19-bedingte Arthritis/Arthropathie--eine wichtige Differentialdiagnose der chronischen Polyarthritis.

INTRODUCTION/AIMS: The differential diagnosis of rheumatoid arthritis (RA) and parvovirus-B19-induced arthritis/arthropathy (PBA) can be difficult, but is of importance because of the different therapeutic implications. The purpose is to describe characteristic features serving to differentiate between chronic PBA and RA, based on 6 personal cases and the literature. METHODS/PATIENTS: 6 patients presenting with acute (3 cases) or chronic PBA (3 cases) over the last 5 years are described. RESULTS/CONCLUSIONS: The demonstration of anti-parvovirus-B19-immunoglobulins (Ig)M in addition to anti-parvovirus-B19-IgG is the most important diagnostic finding. Measurement of IgM must be done within the first months after onset, as it disappears later on. Furthermore, history of disease (exposure, prodromi and acute onset of arthritis), clinical examination (rash) and further investigations (normal ESR and CRP, typical hematologic findings, examination of synovial tissue and fluid without inflammatory changes, demonstration of the genome of parvovirus B19 by polymerase chain reaction, no erosions on radiographs) support the diagnosis of PBA. 2 of the 3 patients with chronic PBA fulfilled the criteria for classification of RA. Therapeutic approaches in PBA are discussed. In contrast to the favourable effect in RA, immunosuppressive agents may prolong persistence of virus and disease in PBA.